Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 6, keine Gesamtzahl für „relevant“
Suchtreffer
Begriffe & Kennungen
Koselugo · 4.5 · TPGS is a P-gp inhibitor in vitro and it cannot be excluded that it may cause clinically relevant drug interac
Eintrag öffnenLazcluze · 4.5 · No clinically relevant differences in lazertinib pharmacokinetics were observed when co-administered with gast
Eintrag öffnenLenalidomide Krka d.d. Novo mesto (previously Lenalidomide Krka) · 4.5 · Co-administration of single or multiple doses of dexamethasone (40 mg once daily) has no clinically relevant e
Eintrag öffnenLitak · 4.8 · Summary of the safety profile Very common adverse reactions observed during the three most relevant clinical t
Eintrag öffnenLixiana · 4.3 · Hepatic disease associated with coagulopathy and clinically relevant bleeding risk.
Eintrag öffnenLunsumio · 4.5 · A transient clinically relevant effect on CYP450 substrates with a narrow therapeutic index (e.g. warfarin, vo
Eintrag öffnenLunsumio · 4.5 · A transient clinically relevant effect on CYP450 substrates with a narrow therapeutic index (e.g. warfarin, vo
Eintrag öffnenLyrica · 4.5 · In vivo studies and population pharmacokinetic analysis Accordingly, in in vivo studies no clinically relevant
Eintrag öffnenLyrica · 4.5 · In vivo studies and population pharmacokinetic analysis Accordingly, in in vivo studies no clinically relevant
Eintrag öffnenLyrica · 4.5 · In vivo studies and population pharmacokinetic analysis Accordingly, in in vivo studies no clinically relevant
Eintrag öffnenMavenclad · 4.8 · The most clinically relevant adverse reactions are lymphopenia (25.6%) and herpes zoster (3.0%). The incidence
Eintrag öffnenMayzent · 4.5 · Co-administration with siponimod did not reveal clinically relevant effects on the pharmacokinetics and pharma
Eintrag öffnenMemantine Accord · 4.5 · 22 In a clinical study in young healthy subjects, no relevant effect of memantine on the pharmacokinetics of g
Eintrag öffnenMemantine Accord · 4.5 · In a clinical study in young healthy subjects, no relevant effect of memantine on the pharmacokinetics of gala
Eintrag öffnenMemantine Accord · 4.5 · In a clinical study in young healthy subjects, no relevant effect of memantine on the pharmacokinetics of gala
Eintrag öffnenMemantine Accord · 4.5 · In single-dose pharmacokinetic (PK) studies in young healthy subjects, no relevant active substance- active su
Eintrag öffnenMemantine Accord · 4.5 · In single-dose pharmacokinetic (PK) studies in young healthy subjects, no relevant active substance- active su
Eintrag öffnenMemantine Accord · 4.5 · In single-dose pharmacokinetic (PK) studies in young healthy subjects, no relevant active substance- active su
Eintrag öffnenMinimal klinisch relevante Differenz
Eintrag öffnenMvasi · 4.5 · No clinically relevant interaction of bevacizumab was observed on the pharmacokinetics of co-administered inte
Eintrag öffnen